French | English

Home : Press room > Press releases > Press releases

Contact us

Questions about the Group, products, the financial statements?

> Please fill in this form

Where to meet us?

> View the Group's agenda

Press releases

09/09/2010

BioAlliance Pharma announces participation in the Midcap Event on September 20 and 21, 2010 (PDF - 56 Ko)

07/09/2010

BioAlliance Pharma announces the grant of its European acyclovir Lauriad® patent (PDF - 57 Ko)

26/08/2010

Acyclovir Lauriad®: US registration file submission planned end-2011 (PDF - 102 Ko)

25/08/2010

Consolidated accounts for the first semester of 2010: Significant revenues, Net profit for the first semester reflecting the contribution of licensing agreements, Strongly reinforced cash position (PDF - 90 Ko)

24/08/2010

BioAlliance Pharma announces the launch of Oravig® on the US market by its commercial partner, Strativa/Par Pharmaceutical (PDF - 110 Ko)

04/08/2010

Changes on BioAlliance Pharma General Management (PDF - 70 Ko)

22/07/2010

A record turnover for Q2 2010 reflecting the successful US FDA approval (PDF - 118 Ko)

01/07/2010

Acyclovir Lauriad®: European registration file submission planned for mid-2011 (PDF - 106 Ko)

Next » 1 | 2 | 3